申请人:HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH
公开号:US20220402960A1
公开(公告)日:2022-12-22
The present invention relates to divalent compounds binding to LecA. The compounds are useful to block biofilm formation of
Pseudomonas aeruginosa
. The invention further relates to pharmaceutical compositions comprising these compounds and to therapeutic methods and uses of these compounds, in particular to therapeutic methods and uses for the treatment of
Pseudomonas aeruginosa
infections in a subject. The invention also relates to imaging of infections, such as biofilms produced by
Pseudomonas aeruginosa
, by using these divalent compounds.